Dr. Cammarata is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Chicago
Chicago, IL 60654
Education & Training
- Henry Ford Health/Henry Ford HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
- Western Michigan University Homer Stryker MD School of MedicineResidency, Internal Medicine, 1986 - 1989
- Michigan State University College of Human MedicineClass of 1986
Certifications & Licensure
- MI State Medical License 1987 - 2027
- American Board of Internal Medicine Internal Medicine
- American Academy of Sleep MedicineSleep Medicine
Clinical Trials
- Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections Start of enrollment: 2013 Apr 01
- Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections Start of enrollment: 2014 May 01
- Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea Start of enrollment: 2014 Jan 23
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsPharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints.S M Bhavnani, M Trang, D C Griffith, O Lomovskaya, J P Hammel
Antimicrobial Agents and Chemotherapy. 2022-12-20 - 9 citationsEfficacy of delafloxacin versus moxifloxacin against atypical bacterial respiratory pathogens in adults with community-acquired bacterial pneumonia (CABP): Data from t...Sandra P. McCurdy, Ashley Nenninger, Amanda Sheets, Kara Keedy, Laura Lawrence
International Journal of Infectious Diseases. 2020-08-01 - 26 citationsEfficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results...Sandra P. McCurdy, Kara Keedy, Laura Lawrence, Ashley Nenninger, Amanda Sheets
Antimicrobial Agents and Chemotherapy. 2020-02-21
Press Mentions
- Why This FDA Approval for Pneumonia Treatment Is so HugeJune 19th, 2019
- Melinta Therapeutics to Present at Making a Difference in Infectious Diseases (MAD-ID) 2019 Annual MeetingMay 7th, 2019
- Melinta Therapeutics Announces Multiple Presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)April 8th, 2019
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
- Member
- Fellow
- Member
External Links
- BARDAhttp://Www.medicalcountermeasures.gov
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: